Lewes, DE -- (SBWIRE) -- 09/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Oxford Investments Holdings Inc.(OTCMKTS:OXIHF), AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), Federal Home Loan Mortgage Corp(OTCBB:FMCC), KV Pharmaceutical Co(OTCMKTS:KVPHQ).
Oxford Investments Holdings Inc.(OTCMKTS:OXIHF) ended higher +655.56% and complete the day at $0.0068. The total number of shares changed hands during the day was 38.11 million.
Oxford Investments Holdings Inc., together with its subsidiaries, engages in the business of direct-banking and payment-card solutions.
For How Long OXIHF will Fight for Profitability? Read This Trend Analysis report
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) closed yesterday at $0.078, a +8.64% increase. Around 11.28 million shares were traded. The company is now valued at around $35.96 million.
Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
For How Long AMBS Gloss will Attract Investors? Find out via this report
Federal Home Loan Mortgage Corp(OTCBB:FMCC) moved -0.88 percent lower at $1.12 and traded between $1.11 and $1.14 after opening the day at $1.13. Its performance over 1-year performance after recent close was 325.86%.
Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States. It operates in three segments: Single-Family Guarantee, Investments, and Multifamily.
Why Should Investors Buy FMCC After the Recent Fall? Just Go Here and Find Out
KV Pharmaceutical Co(OTCMKTS:KVPHQ) shares fall, losing -45.71 percent to close at $0.0380. The stock is down around -88.12% this year and -88.12% for the last 12 months. Around 9.53 million shares changed hands yesterday, higher from an-average trading volume of 3.02 million shares.
K-V Pharmaceutical Company operates as a specialty branded pharmaceutical marketing company primarily focusing on women?s health care in the United States. It provides Evamist, a transdermal estrogen therapy, which delivers a low dose of estradiol for the treatment of moderate-to-severe vasomotor symptoms due to menopause; and Makena, a hydroxyprogesterone caproate injection
Will KVPHQ Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/